Implantable medical device with automatic tachycardia detection and control in MRI environments

• US 9,381,371 B2
• Filed: 10/20/2013
• Issued: 07/05/2016
• Est. Priority Date: 12/08/2009
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Stubbs, Scott R., Gilkerson, James O., Doshi, Hiten J., Schuster, Diane
• Primary Examiner(s): Heller, Tammie K
• Application Number:
  US14/058,251
• Publication Number:
  US 20140046390A1
• Time in Patent Office: 989 Days
• US Class Current: 1/1
• CPC Class Codes: A61N 1/056 Transvascular endocardial electrode systems
• CPC Class Codes: A61N 1/086 Magnetic resonance imaging [MRI] compatible leads
• CPC Class Codes: A61N 1/37 Monitoring; Protecting
• CPC Class Codes: A61N 1/3718 Monitoring of or protection against external electromagnetic fields or currents
• CPC Class Codes: A61N 1/3962 in combination with another heart therapy
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

An implantable medical device (IMD) includes a lead having one or more sensing electrodes and one or more therapy delivery electrodes, and a sensor configured to detect the presence of static and time-varying scan fields in a magnetic resonance imaging (MRI) environment. A controller, in electrical communication with the lead and the sensor, is configured to process signals related to tachycardia events sensed via the one or more sensing electrodes and to deliver pacing and shock therapy signals via the one or more therapy delivery electrodes. The controller compares the sensed static and time-varying scan fields to static and time-varying scan field thresholds. The controller controls delivery of anti-tachycardia pacing and shock therapy signals as a function of the detected tachycardia events, the comparison of the sensed static scan field to the static scan field threshold, and the comparison of the time-varying scan fields to the time-varying scan field thresholds.

Claims

1. An implantable medical device (IMD) comprising:

one or more leads configured to sense cardiac signals and deliver therapy signals;

a sensor configured to detect the presence of static and time-varying scan fields in a magnetic resonance imaging (MRI) environment; and

a controller configured to process detect cardiac event based on the cardiac signals, compare the sensed static and time-varying scan fields to static and time-varying scan field thresholds, and control delivery of a first type of stimulation therapy and a second type of stimulation therapy as a function of the detection of the cardiac events, the comparison of the sensed static scan field to the static scan field threshold, and the comparison of the time-varying scan fields to the time-varying scan field thresholds such that;

when the static and time-varying scan field thresholds are exceeded, the controller disqualifies the cardiac events to inhibit delivery of the first type of stimulation therapy and the second type of stimulation therapy, and

when the static scan field threshold is exceeded and the time-varying scan field threshold is not exceeded, the controller processes sensed cardiac events, causes the IMD to deliver the first type of stimulation therapy upon detection of the cardiac events, and inhibits delivery of the second type of stimulation therapy.

2. The IMD of claim 1, wherein the first type of stimulation therapy is a pacing therapy.

3. The IMD of claim 2, wherein the second type of therapy is a shock therapy.

4. The IMD of claim 1, wherein the cardiac events comprise tachycardia events.

5. The IMD of claim 1, wherein the controller processes sensed cardiac events and enables delivery of the first type of stimulation therapy and the second type of stimulation therapy when neither of the static and time-varying scan field thresholds are exceeded.

6. The IMD of claim 1, wherein the controller is operable to switch the IMD between a normal mode and an MRI mode, and wherein the sensor is disabled in the normal mode and the sensor is enabled in the MRI mode.

7. The IMD of claim 1, wherein the controller further controls delivery of the first type of stimulation therapy and the second type of stimulation therapy as a function of programmed therapy settings.

8. A method for operating an implantable medical device (IMD), the method comprising:

sensing for static and time-varying scan fields associated with a magnetic resonance imaging (MRI) environment;

comparing the sensed static and time-varying scan fields to static and time-varying scan field thresholds;

detecting cardiac events; and

controlling delivery of a first type of stimulation therapy and a second type of stimulation therapy as a function of the detected cardiac events, the comparison of the sensed state electromagnetic field to the static scan field threshold, and the comparison of the time-varying scan fields to the time-varying scan field thresholds,

wherein the controlling step comprises causing the IMD to deliver the first type of stimulation therapy and inhibiting the second type of stimulation therapy when a cardiac event is detected, the static scan field threshold is exceeded, and the time-varying scan field threshold is not exceeded, and

wherein the controlling step comprises inhibiting delivery of both of the first type of stimulation therapy and the second type of stimulation therapy when both of the static and time-varying scan field thresholds are exceeded.

9. The IMD of claim 8, wherein the first type of stimulation therapy is a pacing therapy.

10. The IMD of claim 9, wherein the second type of therapy is a shock therapy.

11. The IMD of claim 8, wherein the cardiac events comprise tachycardia events.

12. The method of claim 8, wherein the controlling step comprises:

causing the IMD to deliver both of the first type of stimulation therapy and the second type of stimulation therapy when neither of the static and time-varying scan field thresholds is exceeded.

13. The method of claim 8, wherein the controlling step of inhibiting delivery of both of the first type of stimulation therapy and the second type of stimulation therapy when both of the static and time-varying scan field thresholds are exceeded comprises disqualifying detected cardiac events to inhibit the first type of stimulation therapy and the second type of stimulation therapy from being delivered.

14. The method of claim 8, wherein the controlling step further comprises controlling delivery of the first type of stimulation therapy and the second type of stimulation therapy as a function of programmed therapy settings.

15. The method of claim 8, wherein, prior to the sensing step, the method further comprises:

switching the IMD from a normal mode to an MRI mode.

16. An implantable medical device (IMD) comprising:

one or more leads configured to sense cardiac signals and deliver therapy signals;

a sensor configured to detect the presence of static and time-varying scan fields in a magnetic resonance imaging (MRI) environment; and

a controller configured to detect cardiac events based on the cardiac signals, compare the sensed static and time-varying scan fields to static and time-varying scan field thresholds, and control delivery of a first type of stimulation therapy and a second type of stimulation therapy as a function of the detection of the cardiac events, the comparison of the sensed static scan field to the static scan field threshold, and the comparison of the time-varying scan fields to the time-varying scan field thresholds such that;

when the static and time-varying scan field thresholds are exceeded, the first type of stimulation therapy and the second type of stimulation therapy are both inhibited, and

when the static scan field threshold is exceeded and the time-varying scan field threshold is not exceeded, the second type of stimulation therapy is inhibited and the first type of stimulation therapy is delivered based on detection of the cardiac events.

17. The IMD of claim 16, wherein the first type of stimulation therapy is a pacing therapy.

18. The IMD of claim 17, wherein the second type of therapy is a shock therapy.

19. The IMD of claim 16, wherein the cardiac events comprise tachycardia events.

20. The IMD of claim 16, wherein the controller enables delivery of the first type of stimulation therapy and the second type of stimulation therapy when neither of the static and time-varying scan field thresholds are exceeded.